Subscribe to RSS
DOI: 10.1055/s-0041-1733959
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review
Funding None.Abstract
Although the entities of venous thromboembolism (VTE), deep venous thrombosis, pulmonary embolus, and thromboprophylaxis in adult patients undergoing brain tumor and spine surgery, traumatic brain injury and elective neurosurgical procedures are widely elucidated, the same is not valid when pediatric patients are under consideration. An attempt to review the peculiarities of these patients through a comprehensive bibliographic review is undertaken. We performed a narrative summary of the relevant literature dedicated to pediatric patients, centered on traumatic brain injury, the general incidence of thromboembolic disease in this patient population, the role of low molecular weight heparin (LMWH) in the treatment and prophylaxis of VTE, and its role in elective neurosurgical procedures, including spinal operations. Additionally, the risk of deep venous thrombosis in elective neurosurgical procedures is reviewed. Due to inherent limitations of the current studies, particularly a restricted number of patients, our data are underpowered to give a definitive protocol and guidelines for all the affected patients. Our current conclusions, based only on pediatric patients, argue that there is limited risk of VTE in pediatric patients suffering from brain tumors and that the possibility of VTE is very low in children undergoing elective neurosurgical procedures. There is no consensus regarding the exact incidence of VTE in traumatic brain injury patients. LMWH seems to be a safe and effective choice for the “at risk” pediatric patient population defined as being older than 15 years, venous catheterization, nonaccidental trauma, increased length of hospital stays, orthopaedic (including spinal) surgery, and cranial surgery.
Keywords
thromboprophylaxis - venous thromboembolism - traumatic brain injury - brain tumors - neurosurgical proceduresPublication History
Article published online:
08 October 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Brown MA, Fulkerson DH. Incidence of venous thromboembolism in hospitalized pediatric neurosurgical patients: a retrospective 25-year institutional experience. Childs Nerv Syst 2020; 36 (05) 987-992
- 2 Revel-Vilk S, Chan AK. Anticoagulation therapy in children. Semin Thromb Hemost 2003; 29 (04) 425-432
- 3 Massicotte P, Julian JA, Gent M. et al; REVIVE Study Group. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109 (2-3): 85-92
- 4 Kim SJ, Sabharwal S. Risk factors for venous thromboembolism in hospitalized children and adolescents: a systemic review and pooled analysis. J Pediatr Orthop B 2014; 23 (04) 389-393
- 5 Tuckuviene R, Christensen AL, Helgestad J, Johnsen SP, Kristensen SR. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011; 159 (04) 663-669
- 6 van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139 (05) 676-681
- 7 Andrew M, David M, Adams M. et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83 (05) 1251-1257
- 8 Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr 2004; 145 (04) 563-565
- 9 Landisch RM, Hanson SJ, Cassidy LD, Braun K, Punzalan RC, Gourlay DM. Evaluation of guidelines for injured children at high risk for venous thromboembolism: a prospective observational study. J Trauma Acute Care Surg 2017; 82 (05) 836-844
- 10 Bernstein D, Coupey S, Schonberg SK. Pulmonary embolism in adolescents. Am J Dis Child 1986; 140 (07) 667-671
- 11 Janata K, Holzer M, Domanovits H. et al. Mortality of patients with pulmonary embolism. Wien Klin Wochenschr 2002; 114 (17-18): 766-772
- 12 Klenner AF, Fusch C, Rakow A. et al. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. J Pediatr 2003; 143 (06) 741-745
- 13 Faustino EV, Hanson S, Spinella PC. et al; PROphylaxis against ThRombosis prACTice (PROTRACT) Study Investigators of the PALISI BloodNet. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med 2014; 42 (05) 1232-1240
- 14 Higgerson RA, Lawson KA, Christie LM. et al; National Association of Childrenʼs Hospitals and Related Institutionʼs Pediatric Intensive Care Unit FOCUS group. Incidence and risk factors associated with venous thrombotic events in pediatric intensive care unit patients. Pediatr Crit Care Med 2011; 12 (06) 628-634
- 15 Monagle P, Chan AKC, Goldenberg NA. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e737S-e801S
- 16 Gonda DD, Fridley J, Ryan SL. et al. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients. J Neurosurg Pediatr 2015; 16 (03) 329-334
- 17 Andrade-Campos MM, Montes-Limón AE, Fernandez-Mosteirin N. et al. Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital. Blood Coagul Fibrinolysis 2013; 24 (02) 194-198
- 18 Dix D, Andrew M, Marzinotto V. et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000; 136 (04) 439-445
- 19 Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP. Guidelines for antithrombotic therapy in pediatric patients. J Pediatr 1998; 132 (04) 575-588
- 20 Thompson AJ, McSwain SD, Webb SA, Stroud MA, Streck CJ. Venous thromboembolism prophylaxis in the pediatric trauma population. J Pediatr Surg 2013; 48 (06) 1413-1421
- 21 Levy ML, Granville RC, Hart D, Meltzer H. Deep venous thrombosis in children and adolescents. J Neurosurg 2004; 101 (Suppl. 01) 32-37
- 22 Harris DA, Lam S. Venous thromboembolism in the setting of pediatric traumatic brain injury. J Neurosurg Pediatr 2014; 13 (04) 448-455
- 23 Vu LT, Nobuhara KK, Lee H, Farmer DL. Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg 2008; 43 (06) 1095-1099
- 24 Webster DL, Fei L, Falcone RA, Kaplan JM. Higher-volume hypertonic saline and increased thrombotic risk in pediatric traumatic brain injury. J Crit Care 2015; 30 (06) 1267-1271
- 25 Tabori U, Beni-Adani L, Dvir R. et al. Risk of venous thromboembolism in pediatric patients with brain tumors. Pediatr Blood Cancer 2004; 43 (06) 633-636
- 26 Walsh DC, Kakkar AK. Thromboembolism in brain tumors. Curr Opin Pulm Med 2001; 7 (05) 326-331
- 27 Wen PY, Marks PW. Medical management of patients with brain tumors. Curr Opin Oncol 2002; 14 (03) 299-307
- 28 Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 2000; 89 (03) 640-646
- 29 Brandes AA, Scelzi E, Salmistraro G. et al. Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 1997; 33 (10) 1592-1596
- 30 Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer 2000; 82 (12) 1967-1973
- 31 Sonaglia F, Agnelli G, Baroni M, Severi P, Quintavalla R, D'Angelo SV. Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery. Blood Coagul Fibrinolysis 1999; 10 (08) 459-463
- 32 Scherer AG, White IK, Shaikh KA, Smith JL, Ackerman LL, Fulkerson DH. Risk of deep venous thrombosis in elective neurosurgical procedures: a prospective, Doppler ultrasound-based study in children 12 years of age or younger. J Neurosurg Pediatr 2017; 20 (01) 71-76
- 33 Kaabachi O, Alkaissi A, Koubaa W, Aloui N, Toumi NelH. Screening for deep venous thrombosis after idiopathic scoliosis surgery in children: a pilot study. Paediatr Anaesth 2010; 20 (02) 144-149
- 34 Rohrer MJ, Cutler BS, MacDougall E, Herrmann JB, Anderson Jr FA, Wheeler HB. A prospective study of the incidence of deep venous thrombosis in hospitalized children. J Vasc Surg 1996; 24 (01) 46-49 , discussion 50
- 35 Van Arendonk KJ, Schneider EB, Haider AH, Colombani PM, Stewart FD, Haut ER. Venous thromboembolism after trauma: when do children become adults?. JAMA Surg 2013; 148 (12) 1123-1130
- 36 Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002; 122 (06) 1933-1937
- 37 Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124 (04) 1001-1008
- 38 Parasuraman S, Goldhaber SZ. Venous thromboembolism in children. Circulation 2006; 113 (02) e12-e16
- 39 Setty BA, O'Brien SH, Kerlin BA. Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases. Pediatr Blood Cancer 2012; 59 (02) 258-264
- 40 Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996; 128 (03) 313-318
- 41 Hanson SJ, Faustino EVS, Mahajerin A. et al. Recommendations for venous thromboembolism prophylaxis in pediatric trauma patients: a national, multidisciplinary consensus study. J Trauma Acute Care Surg 2016; 80 (05) 695-701
- 42 Sherrod BA, McClugage III SG, Mortellaro VE, Aban IB, Rocque BG. Venous thromboembolism following inpatient pediatric surgery: analysis of 153,220 patients. J Pediatr Surg 2019; 54 (04) 631-639